Ticagrelor OD tablet (90 mg single dose) administered without water

DRUG2 trials

Sponsors

AstraZeneca

Conditions

BioavailabilityBioequivalenceHealthy Japanese SubjectsHealthy SubjectsPharmacokinetics

Phase 1

Study to Assess the Bioavailability of Ticagrelor OD Tablet vs. IR Tablet

CompletedNCT02400333

AstraZenecaBioavailability, Healthy Subjects

Start: 2015-06-30End: 2015-07-31Updated: 2016-09-29

Study to Assess the Bioequivalence Between Ticagrelor Orodispersible Tablets and Ticagrelor Immediate-release Tablets in Japanese Subjects

CompletedNCT02436577

AstraZenecaBioequivalence, Healthy Japanese Subjects, Pharmacokinetics

Start: 2015-06-30End: 2015-08-31Updated: 2017-01-11

Related Papers

Pharmacokinetic Profiles of Ticagrelor Orodispersible Tablets in Healthy Western and Japanese Subjects.

2017-11-015 citations